2 edition of Operational guidelines on elimination of lymphatic filariasis. found in the catalog.
Operational guidelines on elimination of lymphatic filariasis.
by National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India in New Delhi
Written in English
|Contributions||National Vector Borne Disease Control Programme (India)|
|The Physical Object|
|Pagination||87 p. :|
|Number of Pages||87|
|LC Control Number||2009305711|
Lymphatic filariasis can be eliminated. To achieve that goal, the Global Alliance to Eliminate Lymphatic Filariasis was established and set a target elimination date of Elimination will be achieved primarily through regular mass drug administration in affected communities 1. In most countries, a single dose of two drugs (albendazole and. Lymphatic filariasis is a tropical disease that affects about 70 million people worldwide. 1 It is caused by infection with the parasitic nematodes Wuchereria bancrofti, Brugia malayi, or Brugia timori and is transmitted through mosquitoes. Chronic infection causes lymphatic dysfunction, resulting in progressive, irreversible swelling of the limbs and genitals ().Cited by: 1.
Lymphatic filariasis has long been a highly endemic scourge in the Pacific, with infection rates amongst the highest in the world. In this area, all LF is caused by the species Wuchereria bancrofti, with different ecologies based on the local mosquito vectors (Anopheles, Culex, or Aedes) and the periodicity (time when microfilariae are at highest density in the blood).Cited by: 8. Author Summary Lymphatic filariasis (LF) is caused by infection with filarial worms that are transmitted by mosquito bites. Globally, 36 million are disfigured and disabled by complications such as severe swelling of the legs (elephantiasis) or scrotum (hydrocele). The Global Programme to Eliminate LF (GPELF) aims to interrupt disease transmission through mass drug administration (MDA), and to Cited by:
Lymphatic filariasis (LF) is an important public health problem next to Malaria in India. WHO had recently called on member states to identify the global elimination of LF as a public health priority. The International Task Force for Disease Eradication too had identified LF as one of the seven infectious diseases considered eradicable or potentially eradicable. Several interventions have been tried in Cited by: Background: Lymphatic filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine and albendazole tablets was carried out for the eligible population in Bagalkot and Gulbarga districts.
Arithmeticae summa tripartita, 1499
The morning watch
Full-time undergraduate prospectus.
Bugs Attendance Chart
Romancing the dark in the city of light
Tradition in sculpture.
Critical theory and society
A Manual of the Victorian Residential Tenancies ACT
Report of H.M. Commissioners for inquiring into the condition of Cathedral Churches in England and Wales upon the Cathedral Church of Ripon
Handbook for singers
Power vs. poverty
Symposium on buffalo jumps.
The New-England primer, improved
Fun with junk
finding guide to the picture collection of the Filipiniana Division.
Lymphatic filariasis elimination programme: training module for drug distributors in countries where lymphatic filariasis is not co-endemic with onchocerciasis Part 1 & Part 2 Lymphoedema staff manual: treatment and prevention of problems associated with lymphatic filariasis.
Over million persons are infected with LF, a disease that can be eliminated. Inthe World Health Organization launched The Global Programme to Eliminate Lymphatic Filariasis, with a target elimination date of Elephantiasis is the most severe and dramatic complication of lymphatic filariasis (LF), a chronic infection caused primarily by the filarial parasite Wuchereria bancrofti.
Dracunculiasis is another chronic infection caused by a filaria-like parasite, Dracunculus medinensis, also known as the guinea worm. Although both LF and dracunculiasis are still important public health problems in the.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in response to the call proposed at the 50th World Health Assembly. The goal of the GPELF is to ensure that all the countries where the disease is endemic would have been transmission-free or would have entered post-intervention mass drug administration (MDA) surveillance by Cited by: 2.
Both tests are being used by the endemic countries in Asia as part of the Global Programme for Elimination of Lymphatic Filariasis (GPELF). Other than evaluation studies on the diagnostic sensitivity and specificity of the rapid tests, I was involved in testing of infected individuals at various time points post-treatment, as well as testing of populations post-mass drug administration (MDA).
He now works on the control/elimination of lymphatic filariasis worldwide (especially program monitoring and evaluation), integrated control of tropical diseases, and the clinical and immunological aspects of filarial disease.
Ottesen earned his medical degree from Harvard University and bachelor of arts degree from Princeton. Nupur Roy is currently additional director with Directorate of National Vector Disease Control Programme, Ministry of Health and Family Welfare, Government of India since last four years.
She is the Country Head for the Lymphatic Filariasis and Kala-azar Elimination programmes in India. The Nigeria Federal Ministry of Health is distributing new national guidelines for coimplementation of interventions to eliminate malaria and lymphatic filariasis (elephantiasis).
This combined nationwide strategy is the first of its kind in Africa and will allow the Federal and State Ministries of Health to efficiently protect all Nigerians. In recognition of its eradicability, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) was set up to ensure that the resolution passed by the World Health Assembly in (WHA ) to eliminate LF by was achieved.
2 To achieve the goal of elimination of LF as a public health problem, the GPELF identified two main strategies: preventive chemotherapy to Cited by: Eliminate Lymphatic Filariasis (GPELF) is to eliminate the disease as a public health problem by (1).
The aims of the Programme are (i) to interrupt transmission with mass drug administration and (ii) to manage morbidity and prevent disability.
In mass drug administration, all eligible people in all endemic areas are given a single. of mass drug administration for eliminating lymphatic fi lariasis Introduction Inthe Fift ieth World Health Assembly resolved to eliminate lymphatic fi lariasis (LF) as a public health problem.
In response, the World Health Organization (WHO) established the Global Programme to Eliminate Lymphatic Filariasis.
Programme Review Group (RPRG) for Elimination of Lymphatic Filariasis in the South-East Asia Region, held on Aprilin Colombo, Sri Lanka, reviewed the progress of LF elimination in the Region, identified key issues and made technical and operational recommendations to scale up mass drug administration (MDA) and.
Elimination of Lymphatic Filariasis in (TAS) guidelines issued in In addition, the microfilarial rate declined to less than 1% in Thailand and initiation of the first step in verification of LF elimination is mobilizing operational costs including capacity-building is a challenge for.
LF Elimination: Progress in the Americas. Historically, lymphatic filariasis was endemic in many areas of the Americas. As the region developed, improvements in the standard of living, particularly in water and sanitation, greatly reduced or eliminated LF in most of the Western hemisphere.
Operational guidelines for rapid mapping of Bancroftian filariasis in Africa, revised during an inter-country workshop held in Ouagadougou, 8−12 March Overview Presently, there is inadequate information on the geographical distribution and burden of disease of lymphatic filariasis in Africa on which to establish elimination programmes.
Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, et al. Doxycycline reduces plasma VEGF-C/ sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathogens. Sep;2(9):e Eberhard ML, Lammie PJ. Laboratory diagnosis of filariasis.
Clin Lab Med. Dec;11(4)– Lymphatic filariasis poses a grave threat to India. Over 40% of worldwide cases are found in India. Sincetwo drug therapy for lymphatic filariasis has been in place but the addition of the third drug now will give a boost to the overall campaign.
India has missed earlier deadlines to eradicate the disease by and Eliminate Lymphatic Filariasis (GPELF) on mapping, monitoring and stopping mass drug administration (MDA) and have used large sample sizes to estimate prevalence in the targeted age group. The guidelines surveillance methods should be convened in in order to review operational research protocols and the.
As per the operational guidelines on elimination of lymphatic filariasis, Government of India, coverage rate of 85% and above, which is sustained for a period of five years, is required for elimination of lymphatic filariasis in india.5 As far as Goa was concerned the overall coverage.
A book on lymphatic filariasis was released on the occasion. NIRT also released a commemorative book on him. You have reached your limit for free articles this on: Kasturi Building, Anna Salai,Mount Road, Chennai,Tamil Nadu.
The global initiatives to eliminate lymphatic filariasis as a public health problem by the year have generated a great deal of debate in India, the largest endemic country. This has led to a shift in the focus from control to elimination of the disease. Although the campaign to eliminate filariasis has begun, much more needs to be by: According to medical experts, the worldwide effort to eliminate lymphatic filariasis is on track to potentially succeed by  For similar-looking but causally unrelated podoconiosis, international awareness of the disease will have to increase before elimination is : Filarial worms spread by mosquitos.The elimination of lymphatic filariasis as a public-health problem is currently dependent on the delivery of annual drug treatments to at least 80% of the eligible members of endemic populations.